STOCK TITAN

Constellation Acquisitn Corp I (CSTAF) Financials

CSTAF
FY2025 annual
Revenue Not reported for FY2025
Net Income -$3.2M -1204.8% YoY
EPS (Diluted) Not reported for FY2025
Operating Cash Flow -$470K +37.6% YoY
Market Cap $101.7M as of Aug 27, 2026
Price / Sales n/m no revenue reported
Price / Earnings n/m net loss, so no earnings multiple, FY2025
Price / Book n/m negative shareholder equity, so no book multiple, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Aug 27, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 17, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CSTAF SEC filings page.

This page shows Constellation Acquisitn Corp I (CSTAF) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CSTAF FY2025

The shrinking asset base now sits beneath persistent liability pressure, defining the company’s dominant financial mechanic.

By FY2025, total assets had fallen to $901K from $310.7M in FY2021. Although total liabilities were lower than in FY2021, they still stood at $24.2M, so obligations now sit against a far smaller asset base—a balance-sheet change more consequential than the year's reported net loss.

Cash conversion remains negative but is less severe than the accounting loss: operating cash flow was -$470K against an operating loss of $1.1M in FY2025. Even as SG&A fell from $1.6M in FY2024 to $415K, operations still consumed cash, indicating that lower reported expenses did not produce cash neutrality.

FY2025 current assets were only $42K against current liabilities of $9.9M, leaving little balance-sheet flexibility for near-term obligations. With total equity at -$23.3M after -$19.9M in FY2024, the strain is structural across periods rather than simply a one-year earnings setback.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

Constellation Acquisitn Corp I does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial
1/5

Constellation Acquisitn Corp I passes 1 of 5 computable financial strength tests (4 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).

Earnings Quality No Cash Backing
N/A

Constellation Acquisitn Corp I reported a net loss of $3.2M while operations used $470K of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Net Income
-$3.3M
YoY-1374.2%
QoQ-374.1%

Constellation Acquisitn Corp I reported -$3.3M in net income in Q2 2026. This represents a decrease of 1374.2% from the same quarter a year earlier. Against the prior quarter it is down 374.1%.

Revenue

Not reported for Q2 2026.

EBITDA

Not reported for Q2 2026.

EPS (Diluted)

Not reported for Q2 2026.

Cash & Balance Sheet

Cash & Debt
$18K
YoY+265.9%
QoQ+250.0%
5Y CAGR-57.4%

Constellation Acquisitn Corp I held $18K in cash as of Q2 2026; long-term debt is not reported for that period.

Free Cash Flow

Not reported for Q2 2026.

Dividends Per Share

Not reported for Q2 2026.

Shares Outstanding

Not reported for Q2 2026.

Margins & Returns

None of these metrics is reported for Q2 2026.

Capital Allocation

Share Buybacks
$0
QoQ-100.0%

Constellation Acquisitn Corp I repurchased no shares in Q2 2026. Against the prior quarter it is down 100.0%.

R&D Spending

Not reported for Q2 2026.

Capital Expenditures

Not reported for Q2 2026.

CSTAF Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CSTAF quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
SG&A Expenses$1.1M+325.3%$2.0M+371.6%N/A$248K+1.4%$265K+17.4%$415K-47.4%N/A$245K-66.5%
Operating Income-$1.1M-325.3%-$2.0M-371.6%N/A-$248K-1.4%-$265K-17.4%-$415K+47.4%N/A-$245K+66.5%
Net Income-$3.3M-1374.2%-$687K-53.7%N/A-$1.3M-3631.2%-$221K-207.8%-$447K+9.6%N/A$38K-87.7%

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, EBITDA, Interest Expense, Income Tax, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

CSTAF Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CSTAF quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$691K-19.3%$682K-19.5%$901K-96.8%$873K-96.9%$856K-96.9%$847K-96.8%$28.2M-43.5%$27.8M-43.2%
Current Assets$30K-24.8%$40K-24.8%$42K-32.2%$35K-73.9%$40K-19.0%$54K-58.9%$62K+66.6%$135K-14.8%
Cash & Equivalents$18K+265.9%$5K-43.9%$5K-6.4%$9K+55.5%$5K-31.2%$9K+137.0%$5K+49.8%$6K+356.6%
Short-Term Investments$0$0$0$0$0$0$0$0
Long-Term Investments$0$0$0$0$0$0$0$0
Total Liabilities$21.4M-0.4%$24.6M+16.0%$24.2M-49.7%$22.9M-51.6%$21.5M-53.5%$21.3M-53.4%$48.0M-28.9%$47.2M-27.5%
Current Liabilities$13.0M+37.1%$11.9M+28.8%$9.9M+12.6%$9.8M+16.1%$9.5M+20.1%$9.2M+21.5%$8.8M+34.4%$8.4M+67.3%
Non-Current Liabilities$8.4M-30.0%$12.8M+6.2%$14.2M-63.7%$13.1M-66.2%$12.0M-68.7%$12.0M-68.4%$39.2M-35.7%$38.8M-35.4%
Total Equity-$20.7M-0.4%-$24.0M-17.5%-$23.3M-17.1%-$22.0M-13.3%-$20.6M-8.7%-$20.4M-9.0%-$19.9M-12.4%-$19.4M-20.2%
Retained Earnings-$20.7M-0.4%-$24.0M-17.5%-$23.3M-17.1%-$22.0M-13.3%-$20.6M-8.7%-$20.4M-9.0%-$19.9M-12.4%-$19.4M-20.2%

Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.

CSTAF Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CSTAF quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow-$247K-126.3%-$140K+22.8%-$94K-24.4%-$86K+62.0%-$109K-12.9%-$181K+48.9%-$75K+77.3%-$226K-586.4%
Investing Cash Flow-$15K0.0%$223K-$15K+90.9%-$15K+90.9%-$15K+90.9%N/A-$165K+63.3%-$165K+63.3%
Financing Cash Flow$275K+129.2%-$83K$105K-56.3%$105K-73.1%$120K-54.7%N/A$240K-69.4%$390K-18.9%
Share Buybacks$0$238K$0$0$0N/A$0$0

Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Dividends Paid.

CSTAF Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CSTAF quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Return on Assets-471.1%-445.3pp-100.8%-48.0ppN/A-152.4%-152.6pp-25.8%-26.6pp-52.8%-50.9ppN/A0.1%-0.5pp
Current Ratio0.000.0x0.000.0x0.000.0x0.000.0x0.000.0x0.010.0x0.010.0x0.020.0x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Debt-to-Equity, Asset Turnover, FCF Margin.

Note: Shareholder equity is negative (-$23.3M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.00), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

Is Constellation Acquisitn Corp I profitable?

No, Constellation Acquisitn Corp I (CSTAF) reported a net income of -$3.2M in fiscal year 2025.

What is Constellation Acquisitn Corp I's operating cash flow?

Constellation Acquisitn Corp I (CSTAF) recorded an outflow of $470K in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are Constellation Acquisitn Corp I's total assets?

Constellation Acquisitn Corp I (CSTAF) had $901K in total assets as of fiscal year 2025, including both current and long-term assets.

Constellation Acquisitn Corp I (CSTAF) had a current ratio of 0.00 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Constellation Acquisitn Corp I (CSTAF) had a return on assets of -359.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Constellation Acquisitn Corp I (CSTAF) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $101.7M as of Aug 27, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Constellation Acquisitn Corp I (CSTAF) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $101.7M as of Aug 27, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Constellation Acquisitn Corp I (CSTAF) has negative shareholder equity of -$23.3M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Constellation Acquisitn Corp I (CSTAF) has a Piotroski F-Score of 1 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Constellation Acquisitn Corp I (CSTAF) reported a net loss of $3.2M while operations used $470K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top